ARISTEIA CAPITAL LLC
Q4 2020 13F-HR Holdings
Net value change ($000)
+1,527,908
(63.0%)
New positions
116
Sold out positions
51
Turnover %
66.4%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q3 2020
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| DD | 181,354 | NEW |
| LCID | 79,519 | 529.1% |
| LBRDA | 59,705 | NEW |
| HYG | 59,247 | 1545.3% |
| DAL | 41,656 | 63.8% |
| CHRD | 38,386 | NEW |
| ScION Tech Growth I | 36,243 | NEW |
| HLMN | 33,481 | NEW |
| FTAC Olympus Acquisition Corp. | 29,249 | 292.5% |
| UAL | 26,823 | 94.5% |
Top Reduces (Value $000, Stocks/ETFs)
| AMCX | -39,605 | -100.0% |
| IAC | -21,682 | -100.0% |
| DENBURY INC | -13,108 | -42.1% |
| AM | -12,810 | -43.6% |
| Foley Trasimene Acquisition II | -9,690 | -100.0% |
| Qell Acquisition Corp | -9,658 | -95.1% |
| TMC | -9,116 | -100.0% |
| JOBY | -8,043 | -100.0% |
| Cano Health, Inc. | -7,659 | -100.0% |
| CLOV | -6,895 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
142,213
(3.6% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|